Showing 9 of 9 recruiting trials for “dowling-degos-disease”
DDAVP for Pituitary Adenoma
👨⚕️ Prashant Chittiboina, M.D., National Institute of Neurological Disorders and Stroke (NINDS)📍 1 site📅 Started Mar 2026View details ↗
Baricitinib in the Treatment of Kohlmeier-Degos Disease in Patients With Neurological Involvement
👨⚕️ Cornelia D Cudrici, M.D., National Heart, Lung, and Blood Institute (NHLBI)📍 1 site📅 Started Feb 2026View details ↗
Use of [18F]FET PET-MRI to Improve Detection of Pituitary Adenomas in Cushing's Disease
Fimepinostat, Combination HDAC and Pi3-kinase Inhibitor Tumor-Directed Therapy for Cushing Disease
RecruitingNCT06017193 ↗
Ultrasound for Socket Healing Evaluation
👨⚕️ Oliver Kripfgans, PhD, University of Michigan, Radiology📍 1 site📅 Started Jul 2024View details ↗
RecruitingNCT07335315 ↗
Evaluation of Intraoperative Contrast Enhanced Ultrasound for the Identification of Pituitary Adenoma in Cushing's Disease Compared to Other Pituitary Tumors
RecruitingNCT07463625 ↗
Evaluation of Positron Emission Tomography (PET) With [18F]FET for the Detection of ACTH-Secreting Corticotroph Pituitary Neuroendocrine Tumors.
RecruitingNCT03831958 ↗
Long-Term Follow-Up of Survivors of Pediatric Cushing Disease
👨⚕️ Deborah P Merke, M.D., Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)📍 1 site📅 Started Mar 2019View details ↗
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →